News

Boehringer Ingelheim expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound

Lupin’s proprietary MEKinhibitor compound is planned for clinical development in combination with Boehringer Ingelheim’s emerging KRAS inhibitor pipeline to address KRAS-driven cancers

Read More

Sep 05, 2019

By : Team ABLE

GVK BIO promotes Sudhir Kumar Singh to COO; appoints Ramesh Subramanian as new Chief Commercial Officer

GVK BIO has promoted Sudhir Kumar Singh to the position of Chief Operating Officer and has appointed Ramesh Subramanian as its new Chief Commercial Officer.

Read More

Sep 05, 2019

By : Team ABLE

India to contribute $22 million to Global Fund for AIDS, TB and Malaria for 6th replenishment cycle

India is adequately financing efforts to accomplish the goals of TB, HIV and Malaria elimination and with an increased pledge, India has inched a step closer in this direction by stepping up the Global Fund efforts.

Read More

Sep 04, 2019

By : Team ABLE

Dr Harsh Vardhan reveals India’s pledge of $200,000 for the SEARO health emergency fund

The Health Ministers of the South-East Asia Region of WHO also signed the Delhi Declaration on Emergency Preparedness.

Read More

Sep 04, 2019

By : Team ABLE

Zydus to launch DCGI-approved biologic drug for rabies

Twinrab and Twinrab (RabiMabs), approved by the DCGI, is the first-of-its-kind, next-gen therapy for treating rabies

Read More

Sep 04, 2019

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights